Navigating the Immune Landscape: Balancing Efficacy and Toxicity of BCMA-Targeting Agents in Multiple Myeloma.
This review synthesizes current evidence on balancing the efficacy and toxicity of BCMA targeted therapies and details the mechanisms driving key immune related toxicities including cytokine release syndrome, immune effector cell associated neurotoxicity syndrome, and immune effector cell-associated hemophagocytic lymp...